HEALTHCARE PROFESSIONAL AREA
Adacyte Therapeutics is a multinational company committed to the development of unique health technologies aimed at improving patients’ health and its quality of life.
Our commitment is taking care of your health
The rationale for the use of granulocyte-monocyte apheresis (GMA) in the treatment of IBD
Have access to courses for Continuing Medical Education (CME) and gain new knowledge, skills and abilities that will enhance your competence and expertise in therapeutic apheresis.
- When more is needed: Adacolumn®, the synergy of a non-drug treatment (In Spanish) June 16, 2022 13:45-14:45h Palma de Mallorca, Spain
- Il Ruolo dell’Aferesi Terapeutica nella Gestione delle IBD e Patologie Reumatologiche (in Italian) September 27, 2021 16:00-18:00h e-meeting
- When can GMA be useful in UC treatment? (in Spanish) June 17, 2021 16:00-17:30h e-meeting
Contact UsFor more informationContact Us